MAUDE Adverse Event Report: SOFRADIM PRODUCTION SAS MESH SOFRADIM- PARIETEX COMPOSITE MESH; MESH, SURGICAL, POLYMERIC

Model Number PCO1510

Device Problems Material Erosion (1214); Migration or Expulsion of Device (1395); Adverse Event Without Identified Device or Use Problem (2993); Patient Device Interaction Problem (4001)

Patient Problems Abdominal Pain (1685); Abscess (1690); Adhesion(s) (1695); Erosion (1750); Purulent Discharge (1812); Fistula (1862); Unspecified Infection (1930); Inflammation (1932); Pain (1994); Scar Tissue (2060); Scarring (2061); Excessive Tear Production (2235); Hernia (2240); Injury (2348); Fluid Discharge (2686); No Code Available (3191); Unspecified Tissue Injury (4559); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)

Event Type  Injury  

Manufacturer Narrative

If information is provided in the future, a supplemental report will be issued.

Event Description

The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a ventral incisional hernia at previous colostomy site.It was reported that after implant, the patient experienced complex subcutaneous abscess extending in multiple directions with brown pus, infection, dense adhesions, scarring, inadvertent large enterotomy, serosal tear, conversion to open approach and wound left open.Post-operative patient treatment included revision surgery.Due to mesh not being able to be removed, patient might require antibiotics for the rest of her life due to permanent mesh infection.

Event Description

The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a ventral incisional hernia at previous colostomy site, in a laparoscopic repair.It was reported that after underlay implant, the patient experienced complex subcutaneous abscess extending in multiple directions with brown pus, recurrence, mesh erosion, free floating mesh, fistula, infection, dense adhesions, scarring, abdominal pain, lipomatous fatty mass, and serosal tear.Post-operative patient treatment included revision surgery, conversion to open approach and wound left open, inadvertent large enterotomy, debridement and drainage of abscess, lysis of adhesions, small bowel resection, excision of scar tissue and placement of a wound vac, and excision of abdominal wall mass.Due to mesh not being able to be removed, patient might require antibiotics for the rest of her life due to permanent mesh infection.

Manufacturer Narrative

Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.

Event Description

The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a ventral incisional hernia at previous colostomy site, in a laparoscopic repair.It was reported that after underlay implant, the patient experienced complex subcutaneous abscess extending in multiple directions with brown pus, recurrence, mesh erosion, free floating mesh, fistula, infection, dense adhesions, scarring, abdominal pain, lipomatous fatty mass, serosal tear, drainage with debridement of subcutaneous sinus tract, inflammation, perforation, pain, and scar tissue.Post-operative patient treatment included revision surgery, conversion to open approach and wound left open, inadvertent large enterotomy, debridement and drainage of abscess, lysis of adhesions, small bowel resection, excision of scar tissue and placement of a wound vac, and excision of abdominal wall mass, medication, wound vac, enterectomies, and mesh removal.

Manufacturer Narrative

Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.

• Brand Name: MESH SOFRADIM- PARIETEX COMPOSITE MESH
• Type of Device: MESH, SURGICAL, POLYMERIC
• Manufacturer (Section D): SOFRADIM PRODUCTION SAS; 116 avenue du formans; trevoux 01600 ; FR 01600
• Manufacturer (Section G): SOFRADIM PRODUCTION SAS; 116 avenue du formans; trevoux 01600 ; FR 01600
• Manufacturer Contact: justin ellis ; 60 middletown ave.; 8200 coral sea st ne; mounds view,mn, CT 55112 ; 7635265677
• MDR Report Key: 8789390
• MDR Text Key: 150991781
• Report Number: 9615742-2019-02558
• Device Sequence Number: 1
• Product Code: FTL
• Combination Product (y/n): N
• Reporter Country Code: US
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: Consumer
• Reporter Occupation: Non-Healthcare Professional
• Type of Report: Initial,Followup,Followup
• Report Date: 08/08/2022

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Date FDA Received: 07/15/2019
• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Device Operator: Health Professional
• Device Expiration Date: 04/30/2011
• Device Model Number: PCO1510
• Device Catalogue Number: PCO1510
• Device Lot Number: PGC00617
• Was Device Available for Evaluation?: No
• Date Manufacturer Received: 08/03/2022
• Is the Device Single Use?: Yes
• Is This a Reprocessed and Reused Single-Use Device?: No
• Type of Device Usage: Initial
• Patient Sequence Number: 1
• Treatment: PROTACK 5MM SINGLE USE (LOT#P7A1010).; PTACK30 (LOT#: P7A1010).; PTACK30 (LOT#: P7A1010)
• Patient Outcome(s): Required Intervention
• Patient Sex: Female
• Patient Weight: 95 KG